$1.660
-0.030 (-1.78%)At close
OSTX Comparative Benchmarking
In the context of the broader market, OSTX competes directly with industry leaders such as GANX and LONA. With a market capitalization of $74.72M, it holds a significant position in the sector. When comparing efficiency, OSTX's gross margin of N/A stands against GANX's N/A and LONA's N/A. Such benchmarking helps identify whether OS Therapies Inc is trading at a premium or discount relative to its financial performance.
OS Therapies Inc Financial Performance
The company has reported consistent net losses, with Q1 2026 showing a net operating loss of $10.4 million, a 167% increase from the previous year, indicating significant challenges in achieving profitability.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.